HKSE - Delayed Quote HKD

InnoCare Pharma Limited (9969.HK)

Compare
5.530
-0.160
(-2.81%)
At close: January 28 at 12:08:04 PM GMT+8
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-671,340.000
-565,554.000
167,058.000
-172,519.000
Investing Cash Flow
374,970.195
666,914.000
-1,726,354.000
-1,729,965.000
-1,106,948.000
Financing Cash Flow
-268,216.858
1,308.000
3,094,506.000
2,544,807.000
2,237,971.000
End Cash Position
4,988,663.873
4,202,564.000
4,179,984.000
3,237,484.000
2,300,881.000
Capital Expenditure
-149,789.664
-254,655.000
-370,327.000
-171,211.000
-251,266.000
Issuance of Capital Stock
--
9,947.000
2,923,230.000
2,527,459.000
2,355,855.000
Issuance of Debt
1,071,900.000
33,800.000
325,000.000
50,000.000
--
Repayment of Debt
--
-2,500.000
--
--
-9,024.000
Repurchase of Capital Stock
--
-6,300.000
--
--
--
Free Cash Flow
-708,122.496
-925,995.000
-935,881.000
-4,153.000
-423,785.000
12/31/2020 - 3/23/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade